H

Active Director Director/Designated Partner DIN 11877983
DIN 11877983 First appointment Sep 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Hepsibai

Hepsibai is a Director/Designated Partner at Novaire Pharma Private Limited (since 2026).

DIN 11877983
Primary Designation Director/Designated Partner
First Appointment 04 Sep 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Novaire Pharma Private Limited U46497KL2026PTC105428
Director/Designated Partner04 Sep 20262026Active

Board colleagues of Hepsibai

NameDINCompanyDesignation
Anikuttan Wilson HepsibaiNovaire Pharma Private LimitedIndividual Subscriber
Moothar Veettil AkashNovaire Pharma Private LimitedIndividual Subscriber
Syamala K11877982Novaire Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Novaire Pharma Private Limited
Premium access

Shareholding and investment profile for Hepsibai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hepsibai

Hepsibai currently holds 1 directorship: Novaire Pharma Private Limited (Director/Designated Partner, since 04 Sep 2026).

Hepsibai was first appointed on 04 Sep 2026 as Director/Designated Partner at Novaire Pharma Private Limited.

The current boards of Hepsibai's companies include Anikuttan Wilson Hepsibai (Novaire Pharma Private Limited), Moothar Veettil Akash (Novaire Pharma Private Limited), Syamala K (Novaire Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available